.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Baxter
Cipla
Moodys
Chinese Patent Office
Accenture
Cantor Fitzgerald
Julphar
Johnson and Johnson
Boehringer Ingelheim

Generated: November 21, 2017

DrugPatentWatch Database Preview

Perrigo Company Profile

« Back to Dashboard

What is the competitive landscape for PERRIGO, and what generic alternatives to PERRIGO drugs are available?

PERRIGO has two hundred and twelve approved drugs.

There are seven US patents protecting PERRIGO drugs on PERRIGO drugs in the past three years. There is one tentative approval on PERRIGO drugs.

There are ninety patent family members on PERRIGO drugs in twenty-four countries and one hundred and fifteen supplementary protection certificates in twelve countries.

Summary for Perrigo

International Patents:90
US Patents:7
Tradenames:108
Ingredients:92
NDAs:212
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Perrigo
MICONAZOLE NITRATE
miconazole nitrate
CREAM;VAGINAL074760-001May 15, 1997OTCNoNo► Subscribe► Subscribe► Subscribe
Perrigo New York
DESONIDE
desonide
OINTMENT;TOPICAL017426-001Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe
Perrigo R And D
FAMOTIDINE
famotidine
TABLET;ORAL077352-001Jul 27, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe
Perrigo Pharma Intl
ENTOCORT EC
budesonide
CAPSULE;ORAL021324-001Oct 2, 2001ABRXYesYes► Subscribe► Subscribe► Subscribe
Perrigo R And D
IBUPROFEN
ibuprofen
TABLET;ORAL077349-001Jun 21, 2005OTCNoNo► Subscribe► Subscribe► Subscribe
Perrigo Israel
NITROGLYCERIN
nitroglycerin
SPRAY, METERED;SUBLINGUAL091496-001Sep 20, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Perrigo R And D
NICOTINE POLACRILEX
nicotine polacrilex
TROCHE/LOZENGE;ORAL090711-002Jul 10, 2009OTCNoNo► Subscribe► Subscribe► Subscribe
Perrigo R And D
NICOTINE POLACRILEX
nicotine polacrilex
TROCHE/LOZENGE;ORAL077007-001Jan 31, 2006OTCNoNo► Subscribe► Subscribe► Subscribe
Perrigo New York
FLUOCINOLONE ACETONIDE
fluocinolone acetonide
CREAM;TOPICAL086811-001Mar 4, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Perrigo Co
CLOBETASOL PROPIONATE
clobetasol propionate
GEL;TOPICAL075027-001Oct 31, 1997ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Perrigo

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Perrigo Pharma Intl
EVAMIST
estradiol
SPRAY;TRANSDERMAL022014-001Jul 27, 2007► Subscribe► Subscribe
Perrigo Pharma Intl
CLINDESSE
clindamycin phosphate
CREAM;VAGINAL050793-001Nov 30, 2004► Subscribe► Subscribe
Perrigo Pharma Intl
BUTOCONAZOLE NITRATE
butoconazole nitrate
CREAM;VAGINAL019881-001Feb 7, 1997► Subscribe► Subscribe
Perrigo Pharma Intl
CLINDESSE
clindamycin phosphate
CREAM;VAGINAL050793-001Nov 30, 2004► Subscribe► Subscribe
Perrigo Pharma Intl
ENTOCORT EC
budesonide
CAPSULE;ORAL021324-001Oct 2, 2001► Subscribe► Subscribe
Perrigo Pharma Intl
BUTOCONAZOLE NITRATE
butoconazole nitrate
CREAM;VAGINAL019881-001Feb 7, 1997► Subscribe► Subscribe
Perrigo Pharma Intl
EVAMIST
estradiol
SPRAY;TRANSDERMAL022014-001Jul 27, 2007► Subscribe► Subscribe
Perrigo Pharma Intl
BUTOCONAZOLE NITRATE
butoconazole nitrate
CREAM;VAGINAL019881-001Feb 7, 1997► Subscribe► Subscribe
Perrigo Pharma Intl
EVAMIST
estradiol
SPRAY;TRANSDERMAL022014-001Jul 27, 2007► Subscribe► Subscribe
Perrigo Pharma Intl
BUTOCONAZOLE NITRATE
butoconazole nitrate
CREAM;VAGINAL019881-001Feb 7, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for PERRIGO drugs

Drugname Dosage Strength Tradename Submissiondate
clindamycin phosphate
Vaginal Cream2%
CLINDESSE
2/5/2015
butoconazole nitrate
Vaginal Cream2%
GYNAZOLE-1
12/23/2009
budesonide
Enteric Coated Capsules3 mg
ENTOCORT EC
2/1/2008

Premature patent expirations for PERRIGO

Expiration due to failure to pay maintenance fee

Patent Number Expiration Date
► Subscribe ► Subscribe

Non-Orange Book Patents for Perrigo

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,416,778 Pharmaceutical preparations and methods for their regional administration► Subscribe
6,916,487 Transdermal delivery of antiemetics► Subscribe
6,929,801 Transdermal delivery of antiparkinson agents► Subscribe
7,094,422Topical delivery of antifungal agents► Subscribe
6,998,138Topical delivery of anti-alopecia agents► Subscribe
7,387,789Transdermal delivery of non-steroidal anti-inflammatory drugs► Subscribe
8,071,075Dermal penetration enhancers and drug delivery systems involving the same► Subscribe
7,438,203Dermal penetration enhancers and drug delivery systems involving same► Subscribe
6,964,777 Transdermal delivery of antianxiety agents► Subscribe
6,916,486 Transdermal delivery of analgesics► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Perrigo Drugs

Country Document Number Estimated Expiration
Germany69900561► Subscribe
Denmark1769785► Subscribe
Australia2005234689► Subscribe
New Zealand525759► Subscribe
Australia1713497► Subscribe
Luxembourg91973► Subscribe
Portugal1769785► Subscribe
Hong Kong1101553► Subscribe
AustraliaPN814496► Subscribe
Spain2348313► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Perrigo Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0004France► SubscribePRODUCT NAME: DESLORATADINE; PSEUDOEPHEDRINE SULFATE; REGISTRATION NO/DATE: EU/1/07/399/001 20070730
/2015Austria► SubscribePRODUCT NAME: ETHINYLESTRADIOL UND EINE KOMBINATION VON LEVONORGESTREL UND ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: 136021 20150224; FIRST REGISTRATION: SK 17/0017/15-S 20150211
C0022France► SubscribePRODUCT NAME: MONTELUKAST SODIUM; REGISTRATION NO/DATE IN FRANCE: NL 23 133 DU 19980320; REGISTRATION NO/DATE AT EEC: 13 651 DU 19970825
/2001Austria► SubscribePRODUCT NAME: ALITRETINOIN; REGISTRATION NO/DATE: EU/1/00/149/001 20001011
C/GB10/012United Kingdom► SubscribePRODUCT NAME: A COMBINATION OF ACYCLOVIR AND HYDROCORTISONE; REGISTERED: UK PL18191/0001-0001 20091112
973Luxembourg► Subscribe91973, EXPIRES: 20220219
2009004,C0770388Lithuania► SubscribePRODUCT NAME: ESTRADIOLI VALERAS + DIENOGESTUM; NAT. REGISTRATION NO/DATE: LT/1/09/1512/001, 2009 04 06 LT/1/09/1512/002, 2009 04 06 LT/1/09/1512/003 20090406; FIRST REGISTRATION: BE 327792 20081103
09/012Ireland► SubscribePRODUCT NAME: QLAIRA-ESTRADIOL VALERATE/DIENOGEST; NAT REGISTRATION NO/DATE: PA1410/58/1 20090109; FIRST REGISTRATION NO/DATE: BE327792 20081103
90049-3Sweden► SubscribePRODUCT NAME: KLINDAMYCIN (SOM KLINDAMYCINFOSFAT) OCH TRETINOIN; NAT. REG. NO/DATE: MTNR 46193 20130503; FIRST REG.: IR PA1332/043/001 20130322
2012 00035Denmark► SubscribePRODUCT NAME: ET KOMBINATIONSPRODUKT AF NAPROXEN OG ESOMEPRAZOL MAGNESIUM TRIHYDRAT; NAT. REG. NO/DATE: 49583 20120327; FIRST REG. NO/DATE: GB PL 17901/0263-001 20101105
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
US Army
Farmers Insurance
Teva
Johnson and Johnson
Deloitte
Julphar
McKinsey
Chubb
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot